Lv732
4500 积分 2025-07-02 加入
BCMA-directed CAR-T cell therapy induces durable drug-free remission in refractory primary immune thrombocytopenia
1个月前
已完结
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma
3个月前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
9个月前
已完结
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
11个月前
已完结
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
11个月前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
1年前
已完结
Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission
1年前
已完结
Advances in the treatment of systemic lupus erythematosus
1年前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
1年前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
1年前
已完结
皖公网安备34019202002308
